Clinical Trial Update: Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Endostar in combination with CHOP as first-line chemotherapy for peripheral T cell lymphoma; no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Endostar (recombinant human endostatin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: T Cell Lymphoma | Phase 2 | Status: UNKNOWN